- Home
- NRSN vs BEAT Comparison
NRSN vs BEAT Comparison
Compare NRSN & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRSN | BEAT |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | Israel | United States |
| Employees | 16 | 17 |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.3M | 31.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NRSN | BEAT |
|---|---|---|
| Price | $0.59 | $0.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $8.50 | $5.63 |
| AVG Volume (30 Days) | 164.2K | ★ 639.8K |
| Earning Date | 03-31-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $583.67 | $315.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.58 | $0.50 |
| 52 Week High | $2.09 | $4.00 |
Technical Indicators
Market Signals| Indicator | NRSN | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 25.73 | 35.97 |
| Support Level | N/A | $0.52 |
| Resistance Level | $0.74 | $0.79 |
| Average True Range (ATR) | 0.05 | 0.06 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 4.67 | 12.95 |
Price Performance
Historical ComparisonAbout NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.